Imunon (IMNN) Scheduled to Post Quarterly Earnings on Monday

Imunon (NASDAQ:IMNN) will post its quarterly earnings results before the market opens on Monday, May 13th. Analysts expect Imunon to post earnings of ($0.57) per share for the quarter.

Imunon (NASDAQ:IMNN) last announced its earnings results on Thursday, March 28th. The company reported ($0.52) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.59) by $0.07. On average, analysts expect Imunon to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Imunon Trading Down 1.4 %

Imunon stock traded down $0.02 during mid-day trading on Tuesday, hitting $1.29. The stock had a trading volume of 21,365 shares, compared to its average volume of 171,728. The firm has a market capitalization of $12.15 million, a P/E ratio of -0.59 and a beta of 2.04. Imunon has a one year low of $0.48 and a one year high of $2.00. The firm’s 50 day moving average is $1.21 and its 200 day moving average is $0.92.

Analyst Ratings Changes

Separately, HC Wainwright raised their target price on Imunon from $12.00 to $13.00 and gave the stock a “buy” rating in a research note on Monday, April 1st.

Imunon Company Profile

Imunon, Inc, a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development.